# FDA Inspection 1167416 - Bloodworks - March 15, 2022

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/4ac4fd5c-9781-472f-8516-4dcc05d2012d
Source feed: FDA_Inspections

> FDA Inspection 1167416 for Bloodworks on March 15, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167416
- Company Name: Bloodworks
- Inspection Date: 2022-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312856 - 2026-04-15](https://www.keypedia.com/records/fda_inspections/bloodworks/198196d0-6678-4297-ba22-72ec02416b01)
- [FDA Inspection 1167416 - 2022-03-15](https://www.keypedia.com/records/fda_inspections/bloodworks/93f6f393-2575-4c23-85f8-92d2083fc7d0)
- [FDA Inspection 1031409 - 2017-11-02](https://www.keypedia.com/records/fda_inspections/bloodworks/28b8eca4-785d-4248-8587-48b8d7d2bd53)
- [FDA Inspection 904964 - 2014-11-28](https://www.keypedia.com/records/fda_inspections/bloodworks/6767c5ba-9e35-45f9-9402-fc5be7166f6a)
- [FDA Inspection 812004 - 2012-12-13](https://www.keypedia.com/records/fda_inspections/bloodworks/11303ce6-2404-4c58-ae1e-fe7d20325e1e)

Company: https://www.keypedia.com/companies/bloodworks/30ba73e7-0146-4206-9f44-095b277a6eef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d